Perfil
Charles Sherwood is currently Director at Vedanta Biosciences, Inc. and COO, Secretary & General Counsel at PureTech Health Plc since 2021.
Formerly, Mr. Sherwood was Vice President-Legal Counsel at Anika Therapeutics, Inc. Education includes graduate studies at Vanderbilt University and undergraduate studies at Middlebury College.
Cargos activos de Charles Sherwood
| Empresas | Cargo | Inicio |
|---|---|---|
| PURETECH HEALTH PLC | Director de Operaciones | 01/08/2021 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Charles Sherwood.
| Empresas | Cargo | Fin |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Consejero General | 01/08/2021 |
Formación de Charles Sherwood.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
- Bolsa de valores
- Insiders
- Charles Sherwood
















